Advertisement

Topics

Intrinsic Clinical Systems to Attend DIA Annual Meeting in Boston, Massachusetts

06:00 EDT 14 Jun 2018 | PR Web

Intrinsic Clinical Systems announced it will attend the DIA Annual Meeting on June 24 - 28, 2018 in Boston, MA.

BOSTON (PRWEB) June 14, 2018

Intrinsic Clinical Systems will attend DIA’s Annual Meeting, designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. Intrinsic will be discussing its mission to make clinical trial management faster, easier, and less painful. Attendees can visit Intrinsic’s booth showcasing its four key clinical software products—CTMS, eTMF, resource management, and feasibility/site engagement—that help biopharma companies more easily manage their operations.

“We’ve felt the frustration of pharmaceutical software products that are overstuffed with needless features,” said Greg Cohee, Partner at Intrinsic Clinical Systems. “We spent a lot of time getting the user experience right. We’ve heard the industry’s requests for minimal data entry, a simple interface, and a foolproof solution.”

Intrinsic builds contemporary pharma software with streamlined interfaces that integrate with other systems for minimal data entry,” said Eric Lake, Partner at Intrinsic Clinical Systems. “The tool’s clean design was created to make study management, resource management, site feasibility, and time tracking seamless and efficient. The modern design reduces the learning curve to almost nothing.”

“We are thrilled to share our new time tracking tool, InTime, with DIA attendees. We’ve really had a great response thus far with this companion tool to Insights resource management,” continued Eric Lake. “The tool resonates with companies because of its simple and flexible structure, which allows for convenient data entry, seamless integration with Insights, and handy reports.”

“The pharma industry is facing new challenges in study complexity which makes this a pivotal time for more efficient tools. Intrinsic CTMS, InTime, and Insights RM are made for proactive study management and data integration while abandoning all the 'extras' that people never use,” said Matt Kiernan, Partner at Intrinsic Clinical Systems. “We’re also excited to showcase Informer, our site feasibility and engagement tool, which lets sponsors easily collect feasibility survey results while at the same time keeping track of who is contacting which sites. Companies are focusing on improving site relationships, and Informer is built for that purpose.”

Those interested in learning more about Intrinsic Clinical Systems or upcoming events can visit http://www.IntrinsicCS.com. To request additional information, please contact Eric Lake at (973) 945-4482.

About Intrinsic Clinical Systems:
The Intrinsic Clinical Systems mission is to provide elegant, streamlined tools to simplify all aspects of drug development operations so biopharma companies can thrive in today’s competitive and cost-conscious environment. By building software tools that provide high value without multi-million dollar price tags, Intrinsic products let companies large and small manage and simplify operations by leveraging new technologies.

For the original version on PRWeb visit: https://www.prweb.com/releases/2018/06/prweb15560421.htm

NEXT ARTICLE

More From BioPortfolio on "Intrinsic Clinical Systems to Attend DIA Annual Meeting in Boston, Massachusetts"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...